Skip to Content

SZ 469 (Glimepiride and Pioglitazone Hydrochloride 4 mg / 30 mg (base))

Pill with imprint SZ 469 is White, Elliptical / Oval and has been identified as Glimepiride and Pioglitazone Hydrochloride 4 mg / 30 mg (base). It is supplied by Sandoz Inc..

Glimepiride/pioglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glimepiride/pioglitazone 4 mg / 30 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for SZ 469

Glimepiride and Pioglitazone Hydrochloride

SZ 469
4 mg / 30 mg (base)
Elliptical / Oval
Prescription only
Drug Class
Antidiabetic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sandoz Inc.
National Drug Code (NDC)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.